Literature DB >> 26919971

Natural history of brain capillary vascular malformations in hereditary hemorrhagic telangiectasia patients.

Waleed Brinjikji1, Vivek N Iyer2, Giuseppe Lanzino3, Kent R Thielen1, Christopher P Wood1.   

Abstract

BACKGROUND AND
PURPOSE: Brain capillary vascular malformations (CVMs) are known to occur with relatively high frequency in hereditary hemorrhagic telangiectasia (HHT) patients. These lesions are thought to have a benign natural history but this has not been systematically studied. The purpose of our study was to examine the natural history of CVMs in a consecutive series of HHT patients.
MATERIALS AND METHODS: Consecutive patients with untreated CVMs receiving serial imaging were included. Baseline data including demographics, HHT gene mutations, and Curacao diagnostic criteria were collected. The primary outcome was rupture on follow-up. A secondary outcome was new focal neurological deficit or seizure related to the lesion.
RESULTS: 22 patients with 42 CVMs were included. Mean age was 45.9±16.9 years. 18 patients (81.8%) were women and 4 (18.2%) were men. 19 patients (86.4%) had definite HHT and 3 patients (13.6%) had probable HHT. Mean follow-up was 4.6±3.7 years. There were a total of 100.2 patient years of follow-up and 222.5 lesion years. No lesions ruptured on follow-up and no patient had focal neurological deficits or seizures related to the lesions.
CONCLUSIONS: Our study found that CVMs in HHT patients have a benign natural history as no patients had hemorrhage or other symptoms related to these lesions. These findings should be confirmed in additional multicenter longitudinal studies. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Arteriovenous Malformation; Genetic; Hemorrhage

Mesh:

Year:  2016        PMID: 26919971     DOI: 10.1136/neurintsurg-2015-012252

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  5 in total

1.  Comparison of MRI, MRA, and DSA for Detection of Cerebral Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.

Authors:  M Vella; M D Alexander; M C Mabray; D L Cooke; M R Amans; C M Glastonbury; H Kim; M W Wilson; D E Langston; M B Conrad; S W Hetts
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-07       Impact factor: 3.825

Review 2.  Cerebral vascular malformations and their imaging modalities.

Authors:  Atif Zafar; Brian Fiani; Hamid Hadi; Mohammad Arshad; Alessandra Cathel; Muhammad Naeem; Matthew S Parsons; Mudassir Farooqui; Abigail A Bucklin; Michael J Leone; Aqsa Baig; Syed A Quadri
Journal:  Neurol Sci       Date:  2020-04-25       Impact factor: 3.307

Review 3.  Systemic and CNS manifestations of inherited cerebrovascular malformations.

Authors:  Blaine L Hart; Marc C Mabray; Leslie Morrison; Kevin J Whitehead; Helen Kim
Journal:  Clin Imaging       Date:  2021-01-20       Impact factor: 2.420

4.  European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT).

Authors:  Omer F Eker; Edoardo Boccardi; Ulrich Sure; Maneesh C Patel; Saverio Alicante; Ali Alsafi; Nicola Coote; Freya Droege; Olivier Dupuis; Annette Dam Fialla; Bryony Jones; Ujwal Kariholu; Anette D Kjeldsen; David Lefroy; Gennaro M Lenato; Hans Jurgen Mager; Guido Manfredi; Troels H Nielsen; Fabio Pagella; Marco C Post; Catherine Rennie; Carlo Sabbà; Patrizia Suppressa; Pernille M Toerring; Sara Ugolini; Elisabetta Buscarini; Sophie Dupuis-Girod; Claire L Shovlin
Journal:  Orphanet J Rare Dis       Date:  2020-06-29       Impact factor: 4.123

Review 5.  Imaging to intervention: a review of what the Interventionalist needs to Know about Hereditary Hemorrhagic Telangiectasia.

Authors:  Stephanie Sobrepera; Eric Monroe; Joseph J Gemmete; Danial Hallam; Jason W Pinchot; Claire Kaufman
Journal:  CVIR Endovasc       Date:  2021-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.